Authors

Krista Rossi
Latest Article

California Startup Exploring Novel ALS Discovery Platform

A grant from the National Institute of Neurological Disorders and Stroke, which allows for concurrent phase I and II trial design review, will speed up the development of novel treatments for patients with ALS and FTD.

Victor Ferastraoaru, MD
Latest Article

EEG Abnormalities in Acutely Ill Patients With COVID-19

Preliminary findings from a retrospective sample series in the Bronx, New York.

Alexis Boro, MD
Latest Article

EEG Abnormalities in Acutely Ill Patients With COVID-19

Preliminary findings from a retrospective sample series in the Bronx, New York.

Jill M. Giordano Farmer, DO, MPH, Rajesh Pahwa, MD, Daniel E. Kremens, MD, JD, Peter LeWitt, MD, M.Med.Sc, Stuart Isaacson, MD
Nicola Davies, PhD
Latest Article

How Big Data Can Drive Advancements in MS Research

Big data is on the precipice of revolutionizing multiple sclerosis knowledge and treatment.

Danielle B. Cross, MD, MS
Latest Article

Everyone Is Working Hard: Why Shift Work Shouldn't Be Celebrated

Danielle B. Cross, MD, MS, a neurology resident in training, shares her thoughts on why glorifying exhaustion is unhealthy.

Jeffrey M. Kaplan, MD
Elizabeth A. Kichula, MD, PhD

Assistant Professor of Clinical Neurology, Perelman School of Medicine, University of Pennsylvania; Attending Physician, Children's Hospital of Philadelphia

Latest Article

Highly Effective Gene Therapies for SMA: Where Do We Go From Here?

Neuromuscular medicine has entered an era of genetic therapy, opening the doors to questions about possible combination approaches and earlier initiation of treatment.

Cecilia Pessoa Gingerich
Latest Article

FDA Grants Alzheimer Biomarker Test Breakthrough Status

The FDA has granted a Breakthrough Device Designation to the Elecsys beta-Amyloid (1-42) and Elecsys Phospho-Tau (181P) cerebrospinal fluid assays, which can be used in the diagnosis of Alzheimer disease.

Kevin McGehrin, MD

The Neuron Clinic, San Diego, California.

Latest Article

Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

A group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.

Luke Halpern

Assistant editor for Pharmacy Times.

Latest Article

Evolving Approaches to the Diagnosis and Management of Paraneoplastic Neurologic Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD

A duo of experts from Feinberg School of Medicine discussed the growing role of clinical algorithms, risk stratification, and treatment considerations in managing paraneoplastic neurologic syndromes alongside cancer therapies. [WATCH TIME: 4 minutes]

Ellen L. Air, MD, PhD
Latest Article

A Team Approach to Asleep Deep Brain Stimulation

Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.

Neal K. Shah
Neal K. Shah

Chief executive officer at CareYaya Health Technologies.

Latest Article

How Social Robotics and Embodied AI Could Reshape Neurology Care

Neal K. Shah talked about how social robots could support emotional well-being in patients with neurologic conditions by reducing loneliness and promoting engagement in health-related activities.

Melissa Rayhill, MD, FAHS, FAAN

University at Buffalo Jacobs School of Medicine and Biomedical Sciences, The State University of New York

Latest Article

Implementing Headache Training in Residency

Despite a tremendous burden regarding migraine-related disability and expenditure, headache disorders remain underdiagnosed and undertreated, and only a small percentage of patients report satisfaction with the treatment received.

Galina Nesterova, MD
Latest Article

PPD/TFS Fostering Global Awareness in Rare Disorders

Rare Disease Day raises awareness for rare disorders, highlighting challenges, improving detection, and fostering collaboration for treatment advancements.

Sarah Yang, MD

Neurologist at Advanced Neurology of Colorado

Latest Article

An Overview of Therapeutic Options for Amyotrophic Lateral Sclerosis

With an anticipated life expectancy of 3 years from the time of symptom onset, an effective treatment strategy is essential in ALS—and recent therapeutic progress has built a foundation of hope for the community.

Yolanda A. Yu, DO

Pulmonologist, Division of Pediatric Pulmonology and Sleep Medicine, Department of Pediatrics, University of California, Los Angeles

Latest Article

Pediatric Sleep Disorders: Assessment and Treatment

The long-term consequences of untreated—and prevalent—sleep disorders in children and adolescents point to a need for a focus on this field of care.

Rachelle Ramirez
Latest Article

In Memoriam: A Loving Tribute to June Halper

NeurologyLive joins the CMSC in mourning the loss of founder and CEO,June Halper, MSN, APC-C, MSCN, FAAN.

Aishwarya Taneja, MD, FAAP
Latest Article

College Checklist for People Living With Migraine

Transition to college life poses unique challenges for students living with migraine, and a comprehensive checklist helps ensure they are prepared for this critical phase.

Phyllis Zee, MD, PhD

Benjamin and Virginia T. Boshes Professor of Neurology; director, Center for Circadian and Sleep Medicine; and chief, Sleep Medicine, Department of Neurology, Northwestern University Feinberg School of Medicine


Connor Iapoce
Latest Article

FDA Approves Tirzepatide as First Treatment for Obstructive Sleep Apnea and Obesity

Adults with obstructive sleep apnea who receivied tirzepatide achieved an average of up to 20% weight loss and experienced at least 25 fewer breathing interruptions for each hour slept.

Kathrin Doppler, MD
Latest Article

Key Sessions and Real-World Case Learning at PNS 2025: Kathrin Doppler, MD; Vincent Timmerman, PhD, MSc

A pair of committee chairs for the Peripheral Nerve Society’s Annual Meeting shared key sessions and trends clinicians should follow at the upcoming meeting, emphasizing collaboration, trial data, and clinical relevance. [WATCH TIME: 3 minutes]

Lena Lache
Victoria Johnson
Victoria Johnson

Victoria Johnson, Assistant Editor for GeneTherapyLive, joined the MJH Life Sciences team in October 2020, originally writing for NeurologyLive. Follow her on Twitter @VictoriaJNeuro or email her at [email protected]​.

Latest Article

Cure Rare Disease Identifies Toxicity Responsible for DMD Gene Therapy Death

Caution is warranted for older patients with Duchenne muscular dystrophy who are receiving gene therapy, according to details of a patient death in a single patient trial.

Amit Mehta, MD

Resident neurologist, MedStar Georgetown University Hospital, Washington, DC

Latest Article

Read All About It: How On-Demand Therapy Has Changed the PD Landscape

As therapeutic development has advanced in Parkinson disease management, the introduction of on-demand options have extended ON time for patients and altered the paradigm of care.

Claudia Asencio, MA

The Neuron Clinic, San Diego, California.

Latest Article

Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

A group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.

Benjamin Tolchin, MD, MS, FAAN
Latest Article

Clinical Considerations for Pharmacologic Approaches to Functional Seizures: Benjamin Tolchin, MD, FAAN

The director of the Center for Clinical Ethics at Yale New Haven Health outlined how the AAN guidelines address the role of pharmacologic therapies in functional seizures, including what evidence exists and when medications should or should not be used. [WATCH TIME: 3 minutes]

Arwa Bohra, MBBS

All India Institute of Medical Sciences, Bhopal, India

Latest Article

Managing Nonmotor Symptoms: Psychosis in Parkinson Disease

Psychosis is estimated to affect more than half of patients with Parkinson disease, and there is a growing need for improved management and therapeutic development.

Shankar Sadasivan, PhD
Mary A. Meskis

Executive Director, Dravet Syndrome Foundation

Latest Article

Dravet Syndrome Awareness Month: Ways to Get Involved

Mary Meskis, executive director of the Dravet Syndrome Foundation, provided a opportunities the organization is offering in honor of Dravet Syndrome Awareness Month.